Imexon

CAS No. 59643-91-3

Imexon ( Amplimexon;BM 06002 )

Catalog No. M15211 CAS No. 59643-91-3

A 2-cyanoaziridine derivative with antitumor activity in some types of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1233 In Stock
50MG 2502 In Stock
100MG 3330 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Imexon
  • Note
    Research use only, not for human use.
  • Brief Description
    A 2-cyanoaziridine derivative with antitumor activity in some types of cancer.
  • Description
    A 2-cyanoaziridine derivative with antitumor activity in some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma; induces mitochondrial oxidation and induces apoptosis via a pathway involving cleaved caspase-3, caspase-9, and/or caspase-8; an apoptosis inducer agent.Blood Cancer Phase 2 Clinical
  • Synonyms
    Amplimexon;BM 06002
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    59643-91-3
  • Formula Weight
    111.10
  • Molecular Formula
    C4H5N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N2CC2C(N)=N1
  • Chemical Name
    4-Amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ziegler AE, et al. Exp Pathol (Jena). 1977;14(6):321-7.
2. Hersh EM, et al. J Natl Cancer Inst. 1992 Aug 19;84(16):1238-44.
3. Baker AF, et al. Clin Cancer Res. 2007 Jun 1;13(11):3388-94.
molnova catalog
related products
  • Aurintricarboxylic a...

    Aurintricarboxylic acid is a strong inhibitor of topoisomerases and other nucleases.

  • Citric acid

    Citric acid is a weak organic tricarboxylic acid found in citrus fruits.

  • VTP50469

    VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction( Ki: 104 pM) and has potently anti-leukemia activity.